Gene- and Protein-Delivered Zinc Finger-Staphylococcal Nuclease Hybrid for Inhibition of DNA Replication of Human Papillomavirus

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Mino, Takashi ^a   Mori, Tomoaki ^a,b   Aoyama, Yasuhiro ^a,c   Sera, Takashi ^a,b  

^a KYOTO UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c DOSHISHA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; DOUBLE STRANDED DNA; HYBRID PROTEIN; UNCLASSIFIED DRUG; VIRUS DNA; ZINC FINGER STAPHYLOCOCCUS NUCLEASE HYBRID PROTEIN;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY TEST; DNA CLEAVAGE; DNA REPLICATION; DRUG BINDING SITE; DRUG PENETRATION; GENE TARGETING; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 18; IN VITRO STUDY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; POLYMERASE CHAIN REACTION; VIRUS INHIBITION; VIRUS REPLICATION;

DNA REPLICATION; DNA, VIRAL; GENOME, VIRAL; HUMAN PAPILLOMAVIRUS 18; HUMANS; MICROCOCCAL NUCLEASE; PAPILLOMAVIRIDAE; REPLICATION ORIGIN; VIRUS REPLICATION; ZINC FINGERS;

EID: 84874227161     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056633     Document Type: Article

References (52)

1. Sera T, Uranga C, (2002) Rational design of artificial zinc-finger proteins using a nondegenerate recognition code table. Biochemistry 41: 7074-7081.
2. Sera T, (2005) Inhibition of virus DNA replication by artificial zinc-finger proteins. J Virol 79: 2614-2619.
3. Mino T, Hatono T, Matsumoto N, Mori T, Mineta Y, et al. (2006) Inhibition of DNA replication of human papillomavirus by artificial zinc finger proteins. J Virol 80: 5405-5412.
4. Lowy DR, Howley PM (2001) Papillomavirus, p. 2231-2264. In D. M. Knipe, and P. M. Howley (ed.), Fields Virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
5. Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, et al. (1995) Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) study group. J Natl Cancer Inst 87: 796-802.
6. Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, et al. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19.
7. Pisani P, Bray F, Parkin DM, (2002) Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer 97: 72-81.
8. Howley PM, Lowy DR (2001) Papillomavirus and their replication, pp. 2197-2229. In: Knipe DM, Howley PM, editors. Fields Virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
9. Wilson GG, West M, Woytek K, Rangasamy D, (2002) Papillomavirus E1 proteins: form, function, and features. Virus Genes 24: 275-290.
10. Chao S-F, Rocque WJ, Daniel S, Czyzyk LE, Phelps WC, et al. (1999) Subunit affinities and stoichiometries of the human papillomavirus type 11 E1:E2:DNA complex. Biochemistry 38: 4586-4594.
11. Frattini MG, Laimins LA, (1994) Binding of the human papillomavirus E1 origin-recognition protein is regulated through complex formation with the E2 enhancer-binding protein. Proc Natl Acad Sci USA 91: 12398-12402.
12. Titolo S, Pelletier A, Sauvé F, Brault K, Wardrop E, et al. (1999) Role of the ATP-binding domain of the human papillomavirus type 11 E1 helicase in E2-dependent binding to the origin. J Virol 73: 5282-5293.
13. Yasugi T, Benson JD, Sakai H, Vidal M, Howley PM, (1997) Mapping and characterization of the interaction domains of human papillomavirus type 16 E1 and E2 proteins. J Virol 71: 891-899.
14. Zou N, Liu J-S, Kuo S-R, Broker TR, Chow LT, (1998) The carboxyl-terminal region of the human papillomavirus type 16 E1 protein determines E2 protein specificity during DNA replication. J Virol 72: 3436-3441.
15. Mino T, Mori T, Aoyama Y, Sera T, (2008) Cell-permeable artificial zinc-finger proteins as potent antiviral drugs for human papillomaviruses. Arch Virol 153: 1291-1298.
16. Horner SM, DiMaio D, (2007) The DNA binding domain of a papillomavirus E2 protein programs a chimeric nuclease to cleave integrated human papillomavirus DNA in HeLa cervical carcinoma cells. J Virol 81: 6254-6264.
17. Bibikova M, Carroll D, Segal DJ, Trautman JK, Smith J, et al. (2001) Stimulation of homologous recombination through targeted cleavage by chimeric nucleases. Mol Cell Biol 21: 289-297.
18. Rebar EJ, Pabo CO, (1994) Zinc finger phage: Affinity selection of fingers with new DNA-binding specifities. Science 263: 671-673.
19. Choo Y, Klug A, (1994) Selection of DNA binding sites for zinc fingers using rationally randomized DNA reveals coded interactions. Proc Natl Acad Sci USA 91: 11168-11172.
20. Wu H, Yang W-P, Barbas CF, (1995) Binding zinc fingers by selection: Toward a therapeutic application. Proc Natl Acad Sci USA 92: 344-348.
21. Wright DA, Thibodeau-Beganny S, Sander JD, Winfrey RJ, Hirsh AS, et al. (2006) Standardized reagents and protocols for engineering zinc finger nucleases by modular assembly. Nat Protoc 1: 1637-1652.
22. Wayengera M, (2012) Zinc finger arrays binding human papillomavirus type 16 and 18 genomic DNA: precursors of gene-therapeutics for in-situ reversal of associated cervical neoplasia. Theor Biol Med Model 9: 30.
23. Boch J, Scholze H, Schornack S, Landgraf A, Hahn S, et al. (2009) Breaking the code of DNA binding specificity of TAL-type III effectors. Science 326: 1509-1521.
24. Morbitzer R, Elsaesser J, Hausner J, Lahaye T, (2011) Assembly of custom TALE-type DNA binding domains by modular cloning. Nucleic Acids Res 39: 5790-5799.
25. Porteus MH, Carroll D, (2005) Gene targeting using zinc finger nucleases. Nat Biotechnol 23: 967-973.
26. Cathomen T, Joung JK, (2008) Zinc-finger nuclease: the next generation emerges. Mol Ther 16: 1200-1207.
27. Mussolino C, Cathomen T, (2012) TALE nucleases: tailored genome engineering made easy. Curr Opin Biotechnol 23: 644-650.
28. Schiffer JT, Aubert M, Weber ND, Mintzer E, Stone D, et al. (2012) Targeted DNA mutagenesis for the cure of chronic viral infections. J Virol 86: 8920-8936.
29. Tucker PW, Hazen EE, Cooton FA, (1979) Staphylococcal nuclease reviewed: A prototypic study in contemporary enzymology. Mol Cell Biochem 23: 67-86.
30. Pei D, Schultz PG, (1990) Site-specific cleavage of duplex DNA with a λ repressor-staphylococcal nuclease hybrid. J Am Chem Soc 112: 4579-4580.
31. Mineta Y, Okamoto T, Takenaka K, Doi N, Aoyama Y, et al. (2008) Enhanced cleavage of double-stranded DNA by artificial zinc-finger nuclease sandwiched between two zinc-finger proteins. Biochemistry 47: 12257-12259.
32. Bitinaite J, Wah DA, Aggarwal AK, Schildkraut I, (1998) FokI dimerization is required for DNA cleavage. Proc Natl Acad Sci USA 95: 10570-10575.
33. Smith J, Bibikova M, Whitby FG, Reddy AR, Chanrasegaran S, et al. (2000) Requirements for double-strand cleavage by chimeric restriction enzymes with zinc finger DNA-recognition domains. Nucleic Acids Res 28: 3361-3369.
34. Wener PA, Mitchell DJ, Pattabiraman K, Pelkey KT, Steinman L, et al. (2000) The design, synthesis, and evaluation of molecular that enable or enhance cellular uptake: Peptoid molecular transporters. Proc Natl Acad Sci USA 97: 13003-13008.
35. Sambrook JD, Russell DW (2001) Molecular Cloning. A Laboratory Manual 3rd ed., pp. 12.61-12.73, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
36. Hirt B, (1967) Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol 26: 365-369.
37. Peden KWC, Pipas JM, Pearson-White S, Nathans D, (1980) Isolation of mutants of an animal virus in bacteria. Science 209: 1392-1396.
38. Chiang C-M, Ustav M, Stenlund A, Ho TF, Broker TR, et al. (1992) Viral E1 and E2 proteins support replication of homologous and heterologous papillomaviral origins. Proc Natl Acad Sci USA 89: 5799-5803.
39. Del Vecchio AM, Romanczuk H, Howley HPM, Baker CC, (1992) Transient replication of human papillomavirus DNAs. J Virol 66: 5949-5958.
40. Mueller PR, Wold B, (1989) In vivo footprinting of a muscle specific enhancer by ligation mediated PCR. Science 246: 780-786.
41. Ho A, Schwarze SR, Mermelstein SJ, Waksman G, Dowdy SF, (2001) Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo. Cancer Res 61: 474-477.
42. Tachikawa K, Schröder O, Frey G, Briggs SP, Sera T, (2004) Regulation of the endogenous VEGF-A gene by exogenous designed regulatory proteins. Proc Natl Acad Sci USA 101: 15225-15230.
43. Russell J, Botchan MR, (1995) cis-Acting components of human papillomavirus (HPV) DNA replication: linker substitution analysis of the HPV type 11 origin. J Virol 69: 651-660.
44. DiMaio D, Coen DM (2001) Replication strategies of DNA viruses, p. 119-132. In: Knipe DM, Howley PM, editors. Fields Virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
45. Lee D, Kim H, Lee Y, Choe J, (1997) Identification of sequence requirement for the origin of DNA replication in human papillomavirus type 18. Virus Res 52: 97-108.
46. Ishiyama M, Miyazono Y, Sasamoto K, Ohkura Y, Ueno K, (1997) A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability. Talanta 44: 1299-1305.
47. Dowty ME, Williams P, Zhang G, Hagstrom JE, Wolff JA, (1995) Plasmid DNA entry into postmitotic nuclei of primary rat myotubes. Proc Natl Acad Sci USA 92: 4572-4576.
48. Labat-Moleur F, Steffan A-M, Brisson C, Perron H, Feugeas O, et al. (1996) An electron microscopy study into the mechanism of gene transfer with lipopolyamines. Gene Ther 3: 1010-1017.
49. Andrei G, Snoeck R, Piette J, Delvenne P, De Clercq E, (1998) Antiproliferative effects of acyclic nucleoside phosphonates on human papillomavirus (HPV)-harboring cell lines compared with HPV-negative cell lines. Oncol Res 10: 523-531.
50. Gabriel R, Lombardo A, Arens A, Miller JC, Genovese P, et al. (2011) An unbiased genome-wide analysis of zinc-finger nuclease specificity. Nat Biotechnol 29: 816-824.
51. Mussolino C, Morbitzer R, Lütge F, Dannemann N, Lahaye T, et al. (2011) A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity. Nucleic Acids Res 39: 9283-9293.
52. Gaj T, Guo J, Kato Y, Sirk SJ, Barbas CF III, (2012) Targeted gene knockout by direct delivery of zinc-finger nuclease proteins. Nat Methods 9: 805-807.